FDA finalizes guidance on therapeutic protein biosimilars

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesCBERGuidanceRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)